Evidence map›Paper›PMID 35458539›Full record

ArticleViruses2022

SARS-CoV-2 Delta and Omicron Variants Surge in Curitiba, Southern Brazil, and Its Impact on Overall COVID-19 Lethality.

Douglas Adamoski, Valter Antonio de Baura, Ana Carolina Rodrigues, Carla Adriane Royer, Mateus Nóbrega Aoki, Marcel Kruchelski Tschá, Ana Claudia Bonatto, Roseli Wassem, Meri Bordignon Nogueira, Sonia Mara Raboni and 5 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. 20-Month monitoring of SARS-CoV-2 in wastewater of Curitiba, in Southern Brazil.Environmental science and pollution research international · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Douglas AdamoskiBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas 13083-970, Brazil.ORCID 0000-0001-5062-2586
Valter Antonio de BauraDepartment of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba 81530-000, Brazil.
Ana Carolina RodriguesDepartment of Genetics, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.ORCID 0000-0002-3913-233X
Carla Adriane RoyerDepartment of Genetics, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.
Mateus Nóbrega AokiCarlos Chagas Institute, FioCruz, Curitiba 81310-020, Brazil.ORCID 0000-0001-5166-2897
Marcel Kruchelski TscháMolecular Biology Institute of Paraná, Curitiba 81310-020, Brazil.
Ana Claudia BonattoDepartment of Genetics, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.
Roseli WassemDepartment of Genetics, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.
Meri Bordignon NogueiraVirology Laboratory, Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba 80060-900, Brazil.
Sonia Mara RaboniVirology Laboratory, Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba 80060-900, Brazil.
Bernardo Montesanti Machado de AlmeidaHiLab Laboratories, Curitiba 81270-185, Brazil.ORCID 0000-0001-5293-3652
Edvaldo da Silva TrindadeDepartment of Cellular Biology, Federal University of Paraná, Curitiba 81530-000, Brazil.
Daniela Fiori GradiaDepartment of Genetics, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.ORCID 0000-0002-1452-5807
Emanuel Maltempi SouzaDepartment of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba 81530-000, Brazil.
Jaqueline Carvalho de OliveiraDepartment of Genetics, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.
Universidade Federal do Paraná · BRHospital de Clínicas Universidade Federal do Paraná · BRBrazilian Center for Research in Energy and Materials · BRFundação Carlos Chagas · BRInstituto de Biologia Molecular do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening efforts and genomic surveillance are essential tools to evaluate the course of the COVID-19 pandemic and assist the public healthcare system in dealing with an increasing number of infections. For the analysis of COVID-19 cases scenarios in Curitiba, Paraná, Brazil, we performed a diagnosis of positive cases, coupled with genotyping, for symptomatic and asymptomatic members of the Federal University of Paraná. We achieved over 1000 samples using RT-qPCR for diagnosis. The posterior genotyping allowed us to observe differences in the spread of strains in Curitiba, Brazil. The Delta variant was not associated with an infection wave, whereas the rapid Omicron variant spread became dominant in less than one month. We also evaluated the general vaccination coverage in the state, observing a striking reduction in lethality correlated to the vaccinated fraction of the population; although lower lethality rates were not much affected by the Omicron variant wave, the same effect was not translated in the number of infections. In summary, our results provide a general overview of the pandemic's course in Paraná State and how there was reduction in lethality after a combination of multiple infection waves and a large-scale vaccination program.

Indexed as

COVID-19SARS-CoV-2BrazilHumansPandemicscoronavirusdiagnosisdiagnostic techniques and proceduresenvironmentgenotypingomicronpublic healthSARS-CoV-2vaccination

Identifiers

PMID35458539
PMCPMC9027352
OpenAlexW4224277375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.